Seoul National University Bundang Hospital (SNUBH)
Cirrhosis treatment cost in the Republic of Korea typically involves foundational diagnostics like a consultation with a hepatologist ranging from $100 to $200. Major therapeutic interventions such as a liver transplant generally run from $128,000 to $156,900. Expenses depend on the disease stage and clinic specialization, often offering 40-60% savings compared to the United States. Seoul and Incheon are the primary medical hubs.
Typical Cirrhosis Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients with advanced liver failure require multidisciplinary care found at major centers like Asan Medical Center. This facility reports a 90% success rate for organ transplants. For those seeking regenerative options, RE:YOUTH specializes in arterial stem cell therapy. This method delivers cells directly to the liver. High-volume centers like Severance Hospital are best for complex cases needing JCI-accredited safety standards.
| Republic of Korea | Turkey | Austria | |
| Liver transplant | from $128,000 | from $45,000 | from $320,000 |
| Stem cell treatment for liver cirrhosis | - | from $12,000 | from $40,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Cirrhosis treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Cirrhosis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Cirrhosis treatment journey.
Dr. Cheon Won Seok is the Director of Gastroenterology at Naeun Hospital in Incheon. He is a recognized medical advisor for major South Korean networks like KBS and MBC. Dr. Cheon is a board-certified subspecialist in gastrointestinal endoscopy. He works at a KOIHA-accredited facility that treats 20,000 patients annually.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
Dr. Byung-hee Lee is a neurosurgeon at RE:YOUTH Clinic in South Korea. He is a founding member of the Korean Society of Interventional Neurology. He also helped found the Korean Stroke Society. Dr. Lee treats complex conditions like Parkinson's, Alzheimer's, and cerebral aneurysms.
Liver transplantation in Republic of Korea is exceptionally safe, with surgical success rates reaching 97% to 100% at leading centers. South Korea maintains a global lead in living donor liver transplantation, reporting 5-year survival rates between 81% and 83%, significantly higher than the 73% average in the United States.
Bookimed Expert Insight: Data shows that specialized centers like Asan Medical Center handle nearly 50% of the country's transplants, creating a volume-outcome benefit. With over 182,000 patients treated annually and KOIHA safety accreditation, these high-capacity facilities minimize surgical risks through standardized digital imaging and robotic assistance. For international patients, choosing JCI-accredited centers like Severance Hospital provides an extra layer of global safety protocols alongside Korea's high 90% survival benchmarks.
Patient Consensus: Patients note that while surgical quality is world-class, it is important to arrange professional translation and plan for a 2–3 month stay to manage post-operative care and discharge logistics effectively.
Asan Medical Center, Seoul National University Hospital, and Samsung Medical Center are top Korean institutions for advanced cirrhosis management and liver transplantation. These facilities maintain survival rates between 97% and 100%, specializing in living donor liver transplants and complex dual-graft procedures within JCI-accredited environments.
Bookimed Expert Insight: While Asan Medical Center dominates in transplant volume, patients seeking less invasive options for early-stage cirrhosis should consider RE:YOUTH in Cheonan. Bookimed data shows it is the only Korean facility focused solely on arterial stem cell delivery. This provides a targeted alternative when transplant criteria are not yet met.
Patient Consensus: Patients note that living-donor transplants are common and efficient, though non-residents should prepare for high out-of-pocket costs and mandatory three-month stays for monitoring.
Patients typically stay in Korea for 2 to 4 months for a liver transplant. This timeframe includes approximately 10 days for pre-operative donor compatibility screening, 21 to 43 days of inpatient hospitalization, and 1 to 2 months of localized outpatient monitoring before safe long-haul air travel.
Bookimed Expert Insight: While major centers like Asan Medical Center report a 90% success rate for organ transplants, the hospital stay is only half the journey. Data shows that Seoul clinics often require outpatient visits every 1–2 weeks during the second month to manage immunosuppressant levels effectively. Choosing a clinic in Seoul, where the highest concentration of JCI-accredited facilities exists, simplifies this frequent local travel.
Patient Consensus: Patients note it is important to budget for at least 3 months because complications like infections or MELD score fluctuations can quickly extend the initial timeline. Securing lodging near the hospital is vital as surgeons will not clear patients for flights until stability is confirmed.
South Korean stem cell therapy for decompensated cirrhosis is technically available through specialized regenerative medicine frameworks rather than general clinical approval. While the 2025 Advanced Regenerative Medicine Act permits access at 112 designated hospitals, treatments like Cellgram-LC remain investigational and are currently undergoing Phase 3 trials.
Bookimed Expert Insight: While major centers like Asan Medical Center report organ transplant success rates from 90%, patients seeking stem cells often overlook specialized clinics. RE:YOUTH Clinic is unique for its arterial delivery method, which aims to provide 100% targeted distribution to the liver compared to traditional intravenous injections.
Patient Consensus: Patients note that while Korean clinics are highly innovative, results for end-stage liver disease can vary significantly. Many emphasize that these treatments should not replace a transplant evaluation, as long-term data on survival benefits is still developing.
Foreign patients can undergo a living-donor liver transplant in South Korea using a relative from another country. Success rates for organ transplants at major centers like Asan Medical Center reach 90%. Procedures require strict genetic matching, legal relationship verification, and mandatory psychological evaluations for both parties.
Bookimed Expert Insight: While many countries have years-long waiting lists, South Korea stands out for efficiency, with some patients starting the process in under 1 month. Asan Medical Center and Seoul National University Hospital (SNUH) have dedicated international departments that routinely handle complex cases from the UAE and Mongolia. This established infrastructure helps navigate the medical visa process, which is essential for relatives traveling from abroad.
Patient Consensus: Patients note that proving family ties with DNA tests early is vital to avoid delays. They also emphasize budgeting for an extended 3-month stay in Korea to ensure the donor recovers safely before flying home.
International patients in South Korea benefit from dedicated coordination centers providing 24/7 medical interpretation, multilingual documentation, and comprehensive repatriation logistics. Leading facilities in Seoul utilize digital healthcare systems to ensure seamless record transfers and virtual follow-up consultations with specialized hepatologists for cirrhosis management.
Bookimed Expert Insight: While major centers like Asan Medical Center achieve 90% organ transplant success, the real value for international patients lies in their high-volume infrastructure. These institutions manage over 10,000 patients daily, leading to highly standardized international departments that specialize in translating complex hepatology jargon for foreign families.
Patient Consensus: Patients note that while English-speaking coordinators are often available during hospital stays, it is vital to secure digital access to English medical records before leaving to ensure local doctors can manage ongoing cirrhosis care.
Living donor liver transplantation in South Korea achieves survival rates of 89.9% to 98% after one year. Leading JCI-accredited Seoul centres report 5-year survival rates exceeding 80%. These outcomes often surpass Western standards through surgical techniques and specialised donor-matching protocols for cirrhosis patients.
Bookimed Expert Insight: South Korea leads the world in clinical experience for living donor transplants. Asan Medical Center performs nearly half of the country's heart transplants. It also maintains high-volume liver programmes. This concentration of cases allows surgeons to perfect right-lobe graft techniques. These methods significantly improve safety for the living donor.
Patient Consensus: Patients often highlight quick donor evaluations and shorter waiting times than the Australian healthcare system. Many note the high level of technical skill and intensive follow-up care provided during their stay in Seoul.
Asan Medical Center and Severance Hospital lead Seoul's medical care system. They are globally recognised for liver cirrhosis treatment. These centres hold JCI and KOIHA accreditations. They offer specialised services including liver transplantation and arterial stem cell therapy.
Bookimed Expert Insight: South Korea's liver care landscape is defined by high specialisation and volume. Asan Medical Center treats over 182,000 patients annually. It serves as a major hub for international medical tourists. For patients seeking non-surgical options, the RE:YOUTH clinic focuses on regenerative medicine. They limit intake to two patients daily for intensive medical attention.
South Korean hospitals provide non-surgical cirrhosis management through antiviral therapies, lifestyle medicine, and regenerative stem cell treatments. Specialists like Dr Cheon Won Seok at Na-Eun Hospital use endoscopy to manage complications. Major Seoul centres also offer TIPS procedures to reduce portal vein pressure without open surgery.
Bookimed Expert Insight: Many major hospitals like Asan Medical Center focus on high-volume organ transplants. However, smaller specialised clinics like RE:YOUTH offer a different approach. They limit intake to two patients daily. This provides focused attention for complex regenerative therapies often unavailable in standard surgical units.
Patient Consensus: Patients note that alcohol abstinence and salt reduction are vital for managing ascites. They also emphasise the need for long-term hepatologist review in Korea to monitor progression and screen for liver cancer.
South Korea hosts specialists for liver disease management, particularly in hepatology and liver transplantation. Major centres like Asan Medical Center and Seoul National University Hospital offer specialised care. These facilities hold JCI or GHA accreditations. They maintain high success rates for complex conditions such as cirrhosis.
Bookimed Expert Insight: Many Australian patients look for hepatology care. Korean data shows a unique focus on high-volume digital integration. Clinics like Seoul National University Bundang Hospital use the BESTcare digital system to track patient data. This reduces medical errors and improves safety for international patients managing complex conditions like cirrhosis.